| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |